Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05456841 · ClinicalTrials.gov registry record · NA
Empathic Communication Skills (ECS) Training
A NA study of Lung Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 1,232
- Enrollment target
- 12
- Study locations
NCT05456841: Recruiting NA study of Lung Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
NCT05456841 is a NA study of Lung Cancer that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,232 participants, above the 933-participant average among 409 other Lung Cancer trials with a reported enrollment target (32% higher). The trial reports 12 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05456841, a NA study of Lung Cancer, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,232 participants
- Enrollment target
- 12
- Study locations
Study Summary
Research indicates that perceived stigma within medical encounters is prevalent and problematic for lung cancer patients' well-being and quality of cancer care. Promoting empathic communication appears to be a potentially effective intervention target to help reduce patients' perceptions of stigma within clinical encounters; however, no formal trainings exist that focus on teaching empathic communication to oncology care providers (OCPs). Building upon favorable findings from a prior R21 (R21CA202793) and the importance of developing interventions to address lung cancer stigma, our goal is to conduct a national trial of empathic communication skills (ECS) training to facilitate improvements in the medical and psychosocial care of patients through de-stigmatizing interactions with OCPs for patients diagnosed with lung cancer.
Primary Outcome
A SPA involves a 12-minute video recorded interaction between the Oncology Care Provider/OCP and the Standardized Patient/SP on a given clinical scenario, using standardized scripts by the SP. Each OCP will participate in one SPA prior to their ECS training and one SPA following training or the timed control period. In contrast to clinical consultation recordings with varied clinical situations that do not necessitate the use of all strategies and skills, the semi-structured nature of SPAs permi
Conditions Studied
Interventions
- BEHAVIORAL Empathic Communication Skills (ECS) training
- OTHER Standard of Care participant interaction
Study Locations (12)
Pennsylvania
- Virtua Health (Data Collection Only) - Philadelphia
- University of Pennsylvania (Data Collection Only) - Philadelphia
- Fox Chase Cancer Center (Data Collection Only) - Philadelphia
New York
- Roswell Park Cancer Institute (Data Collection Only) - Buffalo
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
California
- Providence St. Joseph Health (Data Collection Only) - Irvine
Florida
- BAPTIST ALLIANCE - MCI (Data Collection Only) - Miami
Illinois
- Advocate Health Care Network - Libertyville
Kentucky
- University of Kentucky (Data Collection Only) - Lexington
Michigan
- Munson Healthcare (Data Collection Only) - Traverse City
New Jersey
- Hackensack Meridian Health (Data collection only) - Hackensack
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,232 participants |
| Start Date | 2023-04-28 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What NCT05456841 shows while recruiting
NCT05456841 is an interventional study that assigns participants to a tested intervention. Its 1,232 participants enrollment target places it among the larger protocols in the corpus, above the 933-participant average among 409 other Lung Cancer trials with a reported enrollment target (32% higher).
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which Empathic Communication Skills (ECS) training is the first listed.
NCT05456841 lists 12 locations in 9 states (Pennsylvania, New York, California).
Frequently Asked Questions
What is clinical trial NCT05456841 about?
NCT05456841 is a clinical study titled "Empathic Communication Skills (ECS) Training". Research indicates that perceived stigma within medical encounters is prevalent and problematic for lung cancer patients' well-being and quality of cancer care. Promoting empathic communication appears to be a potentially effective intervention target to help reduce patients' perceptions of stigma w...
What is the current status of trial NCT05456841?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,232 participants. The study started on 2023-04-28. Estimated completion is 2026-08-31.
What conditions does trial NCT05456841 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT05456841?
The interventions under investigation include: Empathic Communication Skills (ECS) training (BEHAVIORAL), Standard of Care participant interaction (OTHER).
Who is sponsoring clinical trial NCT05456841?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05456841 being conducted?
This trial has 12 study locations across California, Florida, Illinois, Kentucky, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05456841's enrollment target sits among peer trials
1,232 41st of 409 higher than 369 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05946044 · 1,230 participants · NA
The Osteoarthritis Prevention Study
- NCT06787937 · 1,230 participants · NA
Communicating About Nicotine Reduction in Cigarettes
- NCT06368245 · 1,244 participants
Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions
- NCT06921785 · 1,220 participants · Phase 3
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI